Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
病毒多样性是改进艾滋病毒发病率估计的创新生物标志物
基本信息
- 批准号:10538707
- 负责人:
- 金额:$ 13.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAIDS preventionAdoptedAdvisory CommitteesAfricanAlgorithmsAreaBioinformaticsBiological AssayBiological MarkersBiometryCountryCross-Sectional StudiesDataDevelopmentDevelopment PlansEpidemicEpidemiologyEvaluationExclusionGenetic RecombinationGenomeGenomicsGenotypeHIVHIV GenomeHIV InfectionsHIV-1IncidenceIndividualInfectionInstitutionInterventionLaboratoriesLeadLeadershipLengthLongitudinal StudiesMeasurementMeasuresMentorsMentorshipMethodologyMethodsModelingMolecularMolecular EpidemiologyMonitorOutcomePatientsPersonsPhylogenetic AnalysisPolicy MakerPopulationPrevention ResearchProcessPublic HealthRNAResearchResearch PersonnelResearch Project GrantsResource-limited settingRoleSamplingSensitivity and SpecificitySerologySpecificitySpecimenStudentsSupervisionSurveysTestingTimeTrainingTraining ActivityUncertaintyViralViral GenomeVirusVirus Replicationantiretroviral therapybioinformatics pipelinecareercareer developmentcostcost effectiveexperiencegenome sequencingimprovedinnovationlongitudinal analysislow income countrynext generation sequencingpotential biomarkerpractical applicationpre-exposure prophylaxisprogramsprospectivepublic health emergencyresearch studyresponsescale upscreeningseroconversionskillstooltransmission processtrend
项目摘要
Project Summary
Candidate: Dr Sikhulile Moyo is unwaveringly committed to an overarching career focused on contributing to
ending the HIV epidemic and related public health emergencies. He committed to a career focused on finding
cost-effective tools for estimating the impact of interventions and towards HIV cure research. He envisions
himself as a leader globally, in research aimed towards tracking and eliminating new HIV infections & towards
developing an HIV cure, working with researchers, program implementers and policy makers for rapid and
cost-effective evaluation of interventions. Dr Moyo’s 5-year career development plan is focused on three key
areas: phylogenetics, epidemiology and biostatistics; cross-sectional Incidence and Implementation; and HIV
cure & characterization of early founder viruses, and SARS-COV-2 genomics. In order to achieve his short-
and medium-term career objectives he seeks to: a) develop advanced methodologic and analytic skills in
molecular epidemiology, phylogenetic analysis and bioinformatics; b) expand laboratory expertise in real-time
high-throughput next generation sequencing and accurate and reliable quantification of proviral reservoirs for
advancing HIV cure studies, and c) strengthen leadership abilities particularly in managing large scientific
projects, population-level surveys, and diverse research teams with expertise in different fields, organizational
leadership and student research supervision. Training activities will encompass formal training and
coursework, practical application through the proposed research project, and direct mentorship from my highly
experienced mentorship and advisory team. These activities will draw on the strengths of the mentorship team
and leading research institutions with strong collaborative ties and have a record of mentoring young
investigators to R01 and independence.
Research: The study aims to introduce an innovative approach to estimating HIV incidence, which is very
important for national HIV programs / public health, and also for HIV prevention research, but can be
expensive and challenging to do. The specific aims are: 1) To assess adjusted viral diversity as a potential
biomarker of HIV incidence. 2) To refine results of serological screening in subsets of true- and false-recent
cases, and patients with established infection (ART-naïve and on ART), by adjusted viral diversity. We will test
whether viral diversity within the most informative regions across the HIV-1C genome adjusted for multiplicity
of transmission, recombination, and level of viral replication could be used to refine the results of serological
screening and improve specificity and sensitivity. We expect that the adjusted viral diversity within the most
informative regions will increase specificity and sensitivity in estimation of HIV incidence within the 4 subsets of
individuals targeted in this Aim to ≥95%. Establishing a cost-effective algorithm to estimate incidence is of
critical public health importance in low resource settings.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sikhulile Moyo其他文献
Sikhulile Moyo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sikhulile Moyo', 18)}}的其他基金
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV Incidence
病毒多样性是改进艾滋病毒发病率估计的创新生物标志物
- 批准号:
10676203 - 财政年份:2022
- 资助金额:
$ 13.65万 - 项目类别:
相似海外基金
HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
- 批准号:
495195 - 财政年份:2023
- 资助金额:
$ 13.65万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10013921 - 财政年份:2020
- 资助金额:
$ 13.65万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10181081 - 财政年份:2020
- 资助金额:
$ 13.65万 - 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
- 批准号:
10166309 - 财政年份:2020
- 资助金额:
$ 13.65万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10597008 - 财政年份:2020
- 资助金额:
$ 13.65万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10386931 - 财政年份:2020
- 资助金额:
$ 13.65万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9921510 - 财政年份:2019
- 资助金额:
$ 13.65万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9753631 - 财政年份:2019
- 资助金额:
$ 13.65万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
10265667 - 财政年份:2019
- 资助金额:
$ 13.65万 - 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
- 批准号:
364681 - 财政年份:2017
- 资助金额:
$ 13.65万 - 项目类别: